• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Progress in the diagnosis and treatment of inflammatory bowel disease.炎症性肠病的诊断与治疗进展
Gastroenterol Hepatol (N Y). 2011 Feb;7(2 Suppl 3):3-16.
2
Challenges and progress in pediatric inflammatory bowel disease.小儿炎症性肠病的挑战与进展
Curr Opin Gastroenterol. 2007 Jul;23(4):406-12. doi: 10.1097/MOG.0b013e3281b115c2.
3
Treating beyond symptoms with a view to improving patient outcomes in inflammatory bowel diseases.超越症状进行治疗，旨在改善炎症性肠病患者的预后。
J Crohns Colitis. 2014 Sep;8(9):927-35. doi: 10.1016/j.crohns.2014.02.021. Epub 2014 Apr 6.
4
Research progress of P2X7 receptor in inflammatory bowel disease.P2X7受体在炎症性肠病中的研究进展
Scand J Gastroenterol. 2019 May;54(5):521-527. doi: 10.1080/00365521.2019.1609077. Epub 2019 May 6.
5
An update on diagnostic and prognostic biomarkers in inflammatory bowel disease.炎症性肠病的诊断和预后生物标志物研究进展。
Expert Rev Mol Diagn. 2017 Sep;17(9):835-843. doi: 10.1080/14737159.2017.1364160. Epub 2017 Aug 10.
6
Attitudes toward genetic testing in patients with inflammatory bowel disease.
Eur J Gastroenterol Hepatol. 2007 Apr;19(4):321-7. doi: 10.1097/MEG.0b013e328013e9a8.
7
[Progress in diagnosis and treatment of inflammatory bowel disease. Current trend in surgical therapy].
Nihon Naika Gakkai Zasshi. 2009 Jan 10;98(1):104-9. doi: 10.2169/naika.98.104.
8
The diagnosis of inflammatory bowel disease is often unsupported in clinical practice.在临床实践中，炎症性肠病的诊断往往缺乏依据。
Dig Liver Dis. 2015 Jan;47(1):20-3. doi: 10.1016/j.dld.2014.09.007. Epub 2014 Oct 16.
9
Validity and completeness of the General Practice Research Database for studies of inflammatory bowel disease.用于炎症性肠病研究的全科医疗研究数据库的有效性和完整性。
Pharmacoepidemiol Drug Saf. 2002 Apr-May;11(3):211-8. doi: 10.1002/pds.698.
10
Artificial intelligence in inflammatory bowel disease endoscopy: current landscape and the road ahead.炎症性肠病内镜检查中的人工智能：现状与未来之路。
Ther Adv Gastrointest Endosc. 2021 Jul 14;14:26317745211017809. doi: 10.1177/26317745211017809. eCollection 2021 Jan-Dec.

引用本文的文献

1
Broad Impact of Bowel Urgency in Ulcerative Colitis and Crohn's Disease: US, European, and Japanese Patient and Healthcare Professional Perspectives from the Communicating Needs and Features of IBD Experiences (CONFIDE) Survey.溃疡性结肠炎和克罗恩病中肠道急迫感的广泛影响：来自“炎症性肠病经历的沟通需求与特征”（CONFIDE）调查的美国、欧洲和日本患者及医疗保健专业人员观点
Adv Ther. 2025 Jul 11. doi: 10.1007/s12325-025-03296-3.
2
The Impact of Microbiome Interventions on the Progression and Severity of Inflammatory Bowel Disease: A Systematic Review.微生物群干预对炎症性肠病进展和严重程度的影响：一项系统评价
Cureus. 2024 May 21;16(5):e60786. doi: 10.7759/cureus.60786. eCollection 2024 May.
3
A Multi-mRNA Prognostic Signature for Anti-TNFα Therapy Response in Patients with Inflammatory Bowel Disease.一种用于预测炎症性肠病患者抗TNFα治疗反应的多信使核糖核酸预后标志物。
Diagnostics (Basel). 2021 Oct 14;11(10):1902. doi: 10.3390/diagnostics11101902.
4
Medical Management of Crohn's Disease.克罗恩病的医学管理
Cureus. 2020 May 29;12(5):e8351. doi: 10.7759/cureus.8351.
5
A single nucleotide polymorphism in dopamine beta hydroxylase (rs6271(C>T)) is over-represented in inflammatory bowel disease patients and reduces circulating enzyme.多巴胺β羟化酶（rs6271（C>T））中的单核苷酸多态性在炎症性肠病患者中过度表达，并降低循环酶。
PLoS One. 2019 Feb 28;14(2):e0210175. doi: 10.1371/journal.pone.0210175. eCollection 2019.
6
Mortality Risk of Inflammatory Bowel Disease: A Case-Control Study of New York State Death Records.炎症性肠病的死亡率：纽约州死亡记录的病例对照研究。
Dig Dis Sci. 2019 Jun;64(6):1604-1611. doi: 10.1007/s10620-018-5430-8. Epub 2019 Jan 2.
7
Effect of Anti-TNF Agents on Postoperative Outcomes in Inflammatory Bowel Disease Patients: a Single Institution Experience.抗TNF药物对炎症性肠病患者术后结局的影响：单机构经验
J Gastrointest Surg. 2016 Sep;20(9):1636-42. doi: 10.1007/s11605-016-3194-z. Epub 2016 Jul 12.
8
Thiopurine-methyltransferase variants in inflammatory bowel disease: prevalence and toxicity in Brazilian patients.炎症性肠病中的硫嘌呤甲基转移酶变体：巴西患者中的患病率和毒性
World J Gastroenterol. 2014 Mar 28;20(12):3327-34. doi: 10.3748/wjg.v20.i12.3327.
9
Dietary vitamin B6 intake modulates colonic inflammation in the IL10-/- model of inflammatory bowel disease.饮食维生素 B6 摄入可调节 IL10-/- 模型中炎症性肠病的结肠炎症。
J Nutr Biochem. 2013 Dec;24(12):2138-43. doi: 10.1016/j.jnutbio.2013.08.005. Epub 2013 Oct 2.

本文引用的文献

1
Current directions of biologic therapies in inflammatory bowel disease.炎症性肠病生物治疗的当前方向。
Therap Adv Gastroenterol. 2010 Mar;3(2):99-106. doi: 10.1177/1756283X09356872.
2
Natalizumab for the treatment of Crohn's disease.那他珠单抗用于治疗克罗恩病。
Expert Rev Clin Immunol. 2010 Jul;6(4):513-9. doi: 10.1586/eci.10.38.
3
Risk of cancer in inflammatory bowel disease treated with azathioprine: a UK population-based case-control study.炎症性肠病患者使用硫唑嘌呤治疗后的癌症风险：一项基于英国人群的病例对照研究。
Am J Gastroenterol. 2010 Jul;105(7):1604-9. doi: 10.1038/ajg.2009.745. Epub 2010 Jan 26.
4
Anemia and inflammatory bowel diseases.贫血与炎症性肠病。
World J Gastroenterol. 2009 Oct 7;15(37):4659-65. doi: 10.3748/wjg.15.4659.
5
Revisiting Crohn's disease as a primary immunodeficiency of macrophages.重新审视克罗恩病作为巨噬细胞的原发性免疫缺陷病。
J Exp Med. 2009 Aug 31;206(9):1839-43. doi: 10.1084/jem.20091683. Epub 2009 Aug 17.
6
Disordered macrophage cytokine secretion underlies impaired acute inflammation and bacterial clearance in Crohn's disease.巨噬细胞细胞因子分泌紊乱是克罗恩病中急性炎症受损和细菌清除障碍的基础。
J Exp Med. 2009 Aug 31;206(9):1883-97. doi: 10.1084/jem.20091233. Epub 2009 Aug 3.
7
Clinically meaningful improvement in health-related quality of life in a randomized controlled trial of certolizumab pegol maintenance therapy for Crohn's disease.在一项关于赛妥珠单抗聚乙二醇化修饰物维持治疗克罗恩病的随机对照试验中，与健康相关的生活质量有临床意义的改善。
Am J Gastroenterol. 2009 Aug;104(8):1976-83. doi: 10.1038/ajg.2009.199. Epub 2009 May 26.
8
Importance of nutrition in inflammatory bowel disease.营养在炎症性肠病中的重要性。
World J Gastroenterol. 2009 May 7;15(17):2081-8. doi: 10.3748/wjg.15.2081.
9
Effects of adalimumab maintenance therapy on health-related quality of life of patients with Crohn's disease: patient-reported outcomes of the CHARM trial.阿达木单抗维持治疗对克罗恩病患者健康相关生活质量的影响：CHARM试验的患者报告结局
Am J Gastroenterol. 2008 Dec;103(12):3132-41. doi: 10.1111/j.1572-0241.2008.02175.x. Epub 2008 Oct 3.
10
What is the risk that a child will develop inflammatory bowel disease if 1 or both parents have IBD?如果父母一方或双方患有炎症性肠病，孩子患炎症性肠病的风险有多大？
Inflamm Bowel Dis. 2008 Oct;14 Suppl 2:S22-3. doi: 10.1002/ibd.20575.

Progress in the diagnosis and treatment of inflammatory bowel disease.

作者信息

Loftus Edward V

机构信息

Professor of Medicine Division of Gastroenterology and Hepatology Mayo Clinic Rochester, Minnesota.

出版信息

Gastroenterol Hepatol (N Y). 2011 Feb;7(2 Suppl 3):3-16.

PMID:22457643
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3061012/
Abstract
摘要